Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. 2009

Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
Neuropediatric Unit, Department of Pediatrics, Shaare Zedek Medical Center, the Hebrew University, Jerusalem 91031, Israel. hirschmd@gmail.com

BACKGROUND Recent studies challenge the assumption that hypogonadism in Prader-Willi syndrome (PWS) is due only to hypothalamic dysfunction. OBJECTIVE The aims of the study were to characterize sexual development and reproductive hormones in PWS males and investigate the etiology of hypogonadism. METHODS Physical examination and blood sampling were performed on 37 PWS males, ages 4 months to 32 yr. RESULTS All had a history of undescended testes; age at orchiopexy ranged from 2 months to 6 yr. Pubertal signs were variable, but none achieved full genital development. Anti-Mullerian hormone (AMH) levels in PWS boys were near the lower limits of normal, decreasing from 44.4 +/- 17.8 ng/ml (mean +/- sd) in young children to 5.9 +/- 4.7 ng/ml in adolescents, similar to normal males. In contrast, inhibin B was consistently low (27.1 +/- 36.1 pg/ml) or undetectable in all age groups. In adult males, FSH levels were high (20.3 +/- 18.3 IU/liter), LH levels were normal (4.2 +/- 4.3 IU/liter), and testosterone levels were low (1.87 +/- 1.17 ng/ml). Only two adults had severe hypogonadotropic hypogonadism with undetectable levels of LH and FSH and high AMH levels (34.9 and 36.7 ng/ml), unlike the other nine adults with AMH levels 2.6 +/- 2.1 ng/ml. Androstenedione (1.06 +/- 0.30 ng/ml) and DHEAS (281.1 +/- 143.6 microg/dl) in adult PWS were normal. CONCLUSIONS Pubertal development in PWS is characterized by normal adrenarche, variable hypothalamic dysfunction, and hypogonadism due to a unique testicular defect. Primary testicular dysfunction is a major component of hypogonadism in PWS.

UI MeSH Term Description Entries
D007006 Hypogonadism Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism). Hypergonadotropic Hypogonadism,Hypogonadism, Isolated Hypogonadotropic,Hypogonadotropic Hypogonadism,Hypogonadism, Hypergonadotropic,Hypogonadism, Hypogonadotropic
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011218 Prader-Willi Syndrome An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229) Labhart-Willi Syndrome,Royer Syndrome,Labhart-Willi-Prader-Fanconi Syndrome,Prader Labhart Willi Syndrome,Prader-Labhart-Willi Syndrome,Royer's Syndrome,Willi-Prader Syndrome,Labhart Willi Prader Fanconi Syndrome,Labhart Willi Syndrome,Prader Willi Syndrome,Royers Syndrome,Syndrome, Labhart-Willi,Syndrome, Labhart-Willi-Prader-Fanconi,Syndrome, Prader-Labhart-Willi,Syndrome, Prader-Willi,Syndrome, Royer,Syndrome, Royer's,Syndrome, Willi-Prader,Willi Prader Syndrome
D011627 Puberty A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT. Puberties
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
May 2003, European journal of pediatrics,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
November 1978, Acta paediatrica Scandinavica,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
January 2019, Endocrinology, diabetes & metabolism,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
December 1984, Clinical genetics,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
March 1990, Clinical oncology (Royal College of Radiologists (Great Britain)),
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
March 2016, Journal of clinical and diagnostic research : JCDR,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
July 2021, Journal of clinical medicine,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
November 1999, European journal of pediatrics,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
August 2002, Neurology,
Harry J Hirsch, and Talia Eldar-Geva, and Fortu Benarroch, and Orit Rubinstein, and Varda Gross-Tsur
December 2001, Endocrine reviews,
Copied contents to your clipboard!